- Home
- MI vs CGTX Comparison
MI vs CGTX Comparison
Compare MI & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MI
- CGTX
- Stock Information
- Founded
- MI 2009
- CGTX 2007
- Country
- MI Hong Kong
- CGTX United States
- Employees
- MI N/A
- CGTX N/A
- Industry
- MI Catalog/Specialty Distribution
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- MI Consumer Discretionary
- CGTX Health Care
- Exchange
- MI Nasdaq
- CGTX Nasdaq
- Market Cap
- MI 26.1M
- CGTX 30.0M
- IPO Year
- MI N/A
- CGTX 2021
- Fundamental
- Price
- MI $2.31
- CGTX $0.58
- Analyst Decision
- MI
- CGTX Strong Buy
- Analyst Count
- MI 0
- CGTX 6
- Target Price
- MI N/A
- CGTX $8.30
- AVG Volume (30 Days)
- MI 36.8K
- CGTX 803.2K
- Earning Date
- MI 01-01-0001
- CGTX 03-25-2025
- Dividend Yield
- MI N/A
- CGTX N/A
- EPS Growth
- MI N/A
- CGTX N/A
- EPS
- MI 1.16
- CGTX N/A
- Revenue
- MI $1,273,946.00
- CGTX N/A
- Revenue This Year
- MI N/A
- CGTX N/A
- Revenue Next Year
- MI N/A
- CGTX N/A
- P/E Ratio
- MI $1.89
- CGTX N/A
- Revenue Growth
- MI N/A
- CGTX N/A
- 52 Week Low
- MI $2.05
- CGTX $0.34
- 52 Week High
- MI $16.70
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- MI 37.11
- CGTX 40.43
- Support Level
- MI $2.11
- CGTX $0.57
- Resistance Level
- MI $2.78
- CGTX $0.65
- Average True Range (ATR)
- MI 0.29
- CGTX 0.05
- MACD
- MI -0.01
- CGTX -0.01
- Stochastic Oscillator
- MI 15.75
- CGTX 9.46
About MI NFT Limited
NFT Ltd Formerly Takung Art Co Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.